(Q34357399)

1 August 2017

title

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism (English)

1 reference

1 August 2017

1 reference

Lewis LD

1

1 reference

1 August 2017

Fitzgerald DL

series ordinal

2

1 reference

1 August 2017

Harper PG

series ordinal

3

1 reference

1 August 2017

Rogers HJ

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

725-732

1 reference

Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Cytochrome P-450 spin state: inorganic biochemistry of haem iron ligation and functional significance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Ifosfamide--pharmacology, safety and therapeutic potential

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Reduction of ifosfamide toxicity using dose fractionation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Pharmacokinetics of divided‐dose ifosfamide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Decreased hepatic drug demethylation in patients receiving chemo-immunotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Decreased half life of cyclophosphamide in patients under continual treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368173

Bioavailability of ifosfamide in patients with bronchial carcinoma

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1990.TB03842.X

Experiences with N-Lost phosphamide esters

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1990.TB03842.X

Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma

21 January 2018

1 reference

12 December 2020

Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide

1 reference

12 December 2020

Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite

1 reference

12 December 2020

Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724)

1 reference

12 December 2020

Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations

1 reference

12 December 2020

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography

1 reference

12 December 2020

The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma

1 reference

12 December 2020

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

1 reference

12 December 2020

Pharmacokinetic studies in lung cancer patients

1 reference

12 December 2020

Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment

1 reference

12 December 2020

Activation of the antineoplastic drug isophosphamide by rat liver microsomes

1 reference

12 December 2020

10.1111/J.1365-2125.1990.TB03842.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference